Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beyond Vanilla VC: Tough Times Demand Clever Measures

This article was originally published in Start Up

Executive Summary

A panel at Windhover's recent START-UP Forum made plain that venture capital is not an area--for all its interest in investing in innovation--which takes easily to innovation in its own business model. Panelists discussed some unusual approaches to financing and dealmaking--such as PIPEs (private investments in public equity) and the unique difficulties they bring. Investors are forming syndicates and becoming increasingly cautious; attaching strings to money in ways not deemed necessary before. In difficult and uncertain times like these, it's clear that investors need patience and fortitude, perhaps more than creativity.

Topics

Related Companies

Related Deals

Latest Headlines
See All
UsernamePublicRestriction

Register

SC090751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel